Sector

Novel techniques for mRNA delivery, capping and more will be key to producing more effective vaccines

Biopharma facilities must address the specific needs and concerns of this dynamic sector

Bright ideas are helping drugs and butterflies take flight

In phase 2 of our OSD series, we cover the resurgence of fixed-dose combinations and the pursuit of effective oral delivery for biologics

In phase III of our OSD series, we cover what's on the horizon for the digital metamorphosis of drug delivery, including 3D printing and robot pills.

The science of ADCs makes for an incredible show

Speed and precision make MS the first choice for the real-time monitoring of fermentation and cell culture off-gas

Through discussions that focused on innovative operational approaches as well as powerful patient-hosted sessions, the show sought to remind manufacturers to keep a patient-focused...

In our three-part series, we cover the trajectory of cancer-fighting ADCs in the pharma industry, including the modality’s history, obstacles and success stories

In the third and final part of our series on antibody-drug conjugates, we discuss the recent market buzz and the rise of new conjugated modalities.

In Act 2 of our series on antibody-drug conjugates, we cover improved linker and payload technology

Generics’ longevity hinges on steady, straightforward storytelling

The field is in need of more detailed product understanding to increase product safety without sacrificing efficacy

ATW 2023 celebrated a record-breaking year of approvals, with an eye on new realities